Results 151 to 157 of about 6,638 (157)

Globotriaosylsphingosine (Lyso-Gb3) as a biomarker for cardiac variant (N215S) Fabry disease

Journal of Inherited Metabolic Disease, 2018
Michel Boutin, Tarekegn Geberhiwot, Douglas G. Ward   +2 more
exaly  

Plasma lyso-Gb3: a biomarker for monitoring fabry patients during enzyme replacement therapy

Clinical and Experimental Nephrology, 2017
Takahiro Tsukimura, Tadayasu Togawa, Hitoshi Sakuraba   +2 more
exaly  

Elevated Lyso-Gb3 Suggests the R118C GLA Mutation Is a Pathological Fabry Variant

JIMD Reports, 2018
Kathleen Nicholls, Andrew S Talbot
exaly  

LC–MS/MS analysis of plasma lyso-Gb in Fabry disease

Clinica Chimica Acta, 2012
Michel Boutin, Christiane Auray-Blais, Pamela Lavoie   +2 more
exaly  

Multiplex Tandem Mass Spectrometry Analysis of Novel Plasma Lyso-Gb3-Related Analogues in Fabry Disease

Analytical Chemistry, 2014
Michel Boutin, Christiane Auray-Blais
exaly  

The use and performance of lyso-Gb3 for the diagnosis and monitoring of Fabry disease: A systematic literature review

Molecular Genetics and Metabolism
Albina Nowak, Uma Ramaswami, Michael L West   +2 more
exaly  

Plasma globotriaosylsphingosine as a biomarker of Fabry disease

Molecular Genetics and Metabolism, 2010
Toshihiro Suzuki, Toya Ohashi, Teruo Kitagawa   +2 more
exaly